Lisa von Moltke
Head of Research & Development and Chief Medical OfficerDr. Lisa von Moltke, M.D., FCP, is Head of Research & Development and Chief Medical Officer of Zenas BioPharma, Inc. from March 2025. She served as the Executive Vice President and Chief Medical Officer at Seres Therapeutics Inc. since March 2020 until March 14, 2025. Dr. von Moltke has U.S. and international drug development experience spanning multiple therapeutic areas, including autoimmune diseases, early- and late-stage clinical development and commercialization at both large and smaller emerging growth companies. Dr. von Moltke was a practicing physician and completed a fellowship in clinical pharmacology at Tufts University School of Medicine and had an academic career in pharmacology and developmental therapeutics. Dr. von Moltke serves as Independent Director of Cara Therapeutics, Inc. since November 01, 2022. Previously, Dr. von Moltke worked for Alkermes, Inc., a pharmaceutical company, from June 2015 to December 2019, where she served in roles of increasing seniority, culminating as Senior Vice President and Head of Clinical Development. Beginning in June 2015, Dr. Moltke served as VP Clinical Pharmacology, DMPK and Bioanalytics, was promoted to Head of Clinical Development in November 2015 and became SVP in June 2018. Prior to joining Alkermes, Dr. von Moltke served as Vice President Clinical Pharmacology at Sanofi/Genzyme Corporation, a biotechnology company, from 2009 to 2015 and was US Head Clinical & Exploratory Pharmacology Sciences (CEP) and Early Development. Starting in 2014 she was Head CEP for Japan and China regions. From 2006 to 2009, Dr. von Moltke was Head, Translational Medicine for the Takeda Oncology Company, a biopharmaceutical company, in Cambridge, MA. She has served as President of the American College of Clinical Pharmacology and as the Editor-in-Chief of The Journal of Clinical Pharmacology. Dr. von Moltke earned a B.A. degree at Wellesley College and her M.D. from Michigan State University, College of Human Medicine.
Positions
- Company NameZenas BioPharma, Inc.Stock CodeZBIOPositionHead of Research & Development and Chief Medical OfficerColleagues
- LOLeon Oliver MoulderFounder, CEO & Chairman
- JLJoseph L. FarmerCOO, President, Principal Financial Officer & Principal Accounting Officer
- HSHeinrich SchliekerChief Technical Officer
- HLHaley LakenChief Scientific Officer
- JJJohn Jacob OrloffIndependent Director
- PLPatricia L. AllenIndependent Director
- JRJason Raleigh NunnIndependent Director
- JPJames Patrick BoylanLead Independent Director
